Articoli anno 2006-2007
A
novel prognostic subtype of human hepatocellular carcinoma derived from hepatic
progenitor cells.
Ju-Seog Lee et all.
Nature Medice 2006
A
Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and
Partial Hepatectomy for Small Hepatocellular Carcinoma.
Min-Shan Chen et all.
Annals of Surgery 2006
An
oncolytic adenovirus controlled by a modified Telomerase promoter is attenuated
in telomerase-negative cells, but shows reduced activity in cancer cells.
Sergai Bortolanza et all.
Cancer
incidence in people with hepatitis B or C infection A large community-based
linkage study.
Janaki Amin et all.
Journal of Hepatology. 2006
Capecitabine
for Treatment of Advanced Hepatocellular Carcinoma.
von Delius S, Lersch C, Mayr M, Stock K, Schulte-Frohlinde E, Schmid RM,
Eckel F. 2006
Chronic
Inflammation Associated with Hepatitis C Virus Infection Perturbs Hepatic Transforming
Growth Factor beta Signaling, Promoting Cirrhosis and Hepatocellular Carcinoma.
Koichi Matsuzaki, Miki Murata, Katsunori Yoshida, Go Sekimoto, Yoshiko Uemura,
Noriko Sakaida,
Hepatology. 2007
Detection
of residual tumor after radiofrequency ablation of liver metastasis with dual-modality
PETCT initial results.
Patrick Veit, Gerald Antoch, Hrvoje Stergar, Andreas Bockisc, Michael Forsting.
Eur Radiol. 2006
Diagnosis
of Hepatic Nodules 20 mm or Smaller in Cirrhosis Prospective Validation of the
Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma.
Alejandro Forner, Ram´on Vilana, Carmen Ayuso, Lluý´s Bianchi,
Manel Sol´e, Juan Ram´on Ayuso et all.
Hepatology. 2007
Efficacy
and safety of radiofrequency ablation for perivascular hepatocellular carcinoma
without hepatic inflow occlusion.
K. K. Ng, R. T. Poon, C. M. Lam, J. Yuen, W. K. Tso and S. T. Fan
British Journal of Surgery 2006
Efficacy
of the combination of long-acting release octreotide and tamoxifen in patients
with advanced hepatocellular carcinoma a randomised multicentre phase III study.
G Verset, C Verslype, H Reynaert, I Borbath, P Langlet, A Vandebroek, M Peeters,
G Houbiers,S Francque, M Arvanitakis and J-L Van Laethem.
British Journal of Cancer.2007
Genetic
mutation in hepatic adenoma Seeing is believing.
Pei-Jer Chen.
Journal of Hepatology. 2006
Genotype–Phenotype
Correlation in Hepatocellular Adenoma New Classification and Relationship With
HCC.
Jessica Zucman-Rossi, Emmanuelle Jeannot, Jeanne Tran Van Nhieu, Jean-Yves Scoazec
et all.
Hepatology. 2006
Hepatitis
B- and C-related hepatocellular carcinomas yield different clinical features
and prognosis.
Chien-Hung Chena, Guan-Tarn Huanga, Pei-Ming Yanga, Pei-Jer Chen et all.
European Journal of Cancer. 2006
Hepatocellular
Carcinoma and Sex.
Jack Wands.
N Engl J Med. 2007
Hepatocellular
carcinoma microwave ablation with multiple straight and loop antenna clusters
pilot comparison with pathologic findings.
Nam C. Yu,David S. K. Lu, Steven S. Raman, Damian E. Dupuy, Caroline J. Simon,
Charles Lassman,MD
Bassam I. Aswad,David Ianniti, Ronald W. Busuttil.
Radiology. 2006
Identification
and Characterization of Tumorigenic Liver Cancer StemProgenitor Cells 2007.
Stephanie Ma et all.
Gastroenterology. 2007
Immunotherapy
of hepatocellular carcinoma.
Tim F. Greten, Michael P. Manns, Firouzeh Korangy.
Journal of Hepatology. 2006
Liver
Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients
With Cirrhosis.
Pierre Nahon et all.
Gastroenterology. 2008 in press
Nodular
regenerative hyperplasia The main liver disease in patients with primary hypogammaglobulinemia
and hepatic abnormalities.
Georgia Malamut, Marianne Ziol, Felipe Suarez, Michel Beaugrand.
Journal of Hepatology. 2008
Percutaneous
Radiofrequency Thermal Ablation for Hepatocellular Carcinoma lights and shadows.
A. Baldan, D. Marino, M. De Giorgio, C. Angonese, U. Cillo, A. D’Alessandro,
A. Masotto, M. Massani, M. Mazzucco, E. Miola, D. Neri, D. Paccagnella, G. Pivetta,
A. Stellato, L. Tommasi, F. Tremolada, A. Tufano, G. Zanus, F. Farinati &
On behalf of GENE – GRUPPO EPATOCARCINOMA NORD-EST.
Aliment Pharmacol Ther. 2006
Phase
2 Study of Erlotinib in Patients With Unresectable Hepatocellular Carcinoma.
Melanie B. Thomas, Romil Chadha, Katrina Glover, Xuemei Wang, Jeffrey Morris,
Thomas Brown, Asif Rashid, Janet Dancey, James L.
Cancer. 2007
Postoperative
recurrence in hepatocellular carcinoma Comparison between percutaneous ethanol
injection and radiofrequency ablation.
Kaoru Iwata, Tetsuro Sohda, Shinya Nishizawa, Hidetoshi Nakane, Makoto Yoshikane,
Yasuhiro Koyama, Daisuke Morihara, Yasuaki Takeyama, Yuko Uehara, Yuji Kitamura,
Makoto Irie, Satoshi Syakadou, Masanori Yokoyama, Seiichiro Kamimura, Hiroshi
Watanabe, Shotaro Sakisaka.
Arch Surg. 2006
Radiofrequency
Ablation of Liver Tumors.
LM. Sutherland, JAR. Williams, RTA. Padbury, DC. Gotley, B Stoke, GJ. Maddern.
Arch Surg. 2006
Reviews
in basic and clinical gastroenterology.
El–Serag H. and Lenhard Rudolph K.
Gastroenterology. 2007
Safety
of Percutaneous Ethanol Injection as Neoadjuvant Therapy for Hepatocellular
Carcinoma in Waiting List Liver Transplant Candidates.
J.F. Castroagudý´n, M. Delgado, A. Villanueva, M. Bustamante, J.
Martý´nez, E. Otero, S. Tomé,
S.M. Martý´nez, F.R. Segade, R. Conde, E. Dominguez-Muñoz
and E. Varo.
Transplantation Proceedings. 2005
Southern
Europe as an example of interaction between various environmental factors a
systematic review of the epidemiologic evidence.
F. Donato, U. Gelatti, R.M. Limina and G. Fattovich.
Oncogene. 2006
Survival
benefit of transcatheter arterial chemoembolization in patients with hepatocellular
carcinoma larger than 10 cm in diameter.
Huang YH, Wu JC, Chen SC, Chen CH, Chiang JH, Huo TI, Lee PC, Chang FY, Lee
SD.
Aliment Pharmacol Ther. 2006
Systematic
review evidence-based management of hepatocellular carcinoma – an updated
analysis of randomized controlled trials.
P. M. Lopez, A. Villanueva & J. M. Llovet.
Aliment Pharmacol Ther. 2006
TACE-2
A phaseII III randomised double blinded placebo-controlled trial of sorafenib
in combination with transarterial cheomoembolisation in hepatocellular cancer.
Trial Development Group: T.Meyer, D.Brant, A.Burroughs, J.Garden, P.Johnson,
D.Palmer, J.Primrose, D.Stocken.
2007
The
Bcl-2 apoptotic switch in cancer development and therapy.
JM Adams and S Cory.
Oncogene. 2007
The
contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis
and primary liver cancer worldwide.
JF Perz, GL Armstrong, LA Farrington, YJF Hutin, BP Bell.
Journal of Hepatology. 2006
The
Effect of Menatetrenone, a Vitamin K2 Analog, on Disease Recurrence and Survival
in Patients with Hepatocellular Carcinoma after Curative Treatment.
T Mizuta, I Ozaki, Y Eguchi, T Yasutake, S Kawazoe, K Fujimoto, K Yamamoto.
Cancer. 2006
The
Oscar-worthy role of Myc in apoptosis.
Natalie Meyer, Sam S. Kim, Linda Z. Penn.
Seminars in Cancer Biology. 2006
Viral
hepatitis and liver cancer the case of hepatitis C.
M Levrero.
Oncogene. 2006
Chi siamo Faq Links Reviews News E-mail Casi clinici Immagini